Exact Mass: 438.0984482
Exact Mass Matches: 438.0984482
Found 65 metabolites which its exact mass value is equals to given mass value 438.0984482,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Riboflavin cyclic-4',5'-phosphate
Riboflavin cyclic-4,5-phosphate, also known as cfmn or cyclic flavin mononucleotide, is a member of the class of compounds known as flavins. Flavins are compounds containing a flavin (7,8-dimethyl-benzo[g]pteridine-2,4-dione) moiety, with a structure characterized by an isoalloaxzine tricyclic ring. Riboflavin cyclic-4,5-phosphate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Riboflavin cyclic-4,5-phosphate can be found in a number of food items such as sea-buckthornberry, horseradish tree, malabar spinach, and wild rice, which makes riboflavin cyclic-4,5-phosphate a potential biomarker for the consumption of these food products. Riboflavin cyclic-4,5-phosphate is part of the Glycerolipid metabolism, and RIG-I-like receptor signaling pathway pathways. It is a substrate for: Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing).
Silica aerogel
C23H22N2O3S2 (438.10717819999996)
Silica aerogel is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")
(4S,5E,7Z,12R,14Z,17Z)-4-hydroxy-17,18-didehydrobromovulone-3
C21H27BrO5 (438.10417520000004)
8-Glucuronoyl-xanthurensaeure-N-carboxymethylamid
C18H18N2O11 (438.09105580000005)
(2S,3R)-3,10-dihydroxy-9-O-(6-hydroxy-7-O-methyl-2-hydroxymethyldihydrobenzofuran-3-yl)dibenz--pyran-6-one
Cys Asp Asp Ser
Cys Asp Ser Asp
Cys Ser Asp Asp
Asp Cys Asp Ser
Asp Cys Ser Asp
Asp Asp Cys Ser
Asp Asp Ser Cys
Asp Ser Cys Asp
Asp Ser Asp Cys
7-Carboxynalidixic acid glucuronide
C18H18N2O11 (438.09105580000005)
Ser Cys Asp Asp
Ser Asp Cys Asp
Ser Asp Asp Cys
Nap-Asp-OH
C22H18N2O8 (438.10631079999996)
Asp-Nap-OH
C22H18N2O8 (438.10631079999996)
Silica aerogel
C23H22N2O3S2 (438.10717819999996)
1,1-(BUTANE-1,4-DIYL)BIS[4-AZA-1-AZONIABICYCLO[2.2.2]OCTANE] DIBROMIDE
10-[(2R,3R)-2,3-dihydroxy-3-[(4S)-2-hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]propyl]-7,8-dimethylbenzo[g]pteridine-2,4-dione
(E)-2-hydroxy-1-[4,5,7,10-tetrahydroxy-3-(3-oxobutanoyl)anthracen-2-yl]pent-2-ene-1,4-dione
(2S)-2-amino-5-[[(1R)-1-carboxy-2-(1H-indol-3-ylmethylcarbamothioylsulfanyl)ethyl]amino]-5-oxopentanoic acid
3-Hydroxy-2-(1-hydroxy-3-oxopropan-2-yl)oxy-2-[1-[1-[1-(1-hydroxy-3-oxopropan-2-yl)oxy-2-oxoethoxy]-3-oxopropan-2-yl]oxy-2-oxoethoxy]propanal
2-[[4-amino-5-[4-(difluoromethoxy)phenyl]-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide
2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-acetamido-2-oxo-1-benzopyran-4-yl)methyl ester
N-(4-acetylphenyl)-4-[[(E)-3-(4-fluorophenyl)-3-oxoprop-1-enyl]amino]benzenesulfonamide
C23H19FN2O4S (438.10495060000005)
N-(3-acetylphenyl)-4-[[(E)-3-(4-fluorophenyl)-3-oxoprop-1-enyl]amino]benzenesulfonamide
C23H19FN2O4S (438.10495060000005)
(3aR,4S,9aR,9bS)-N-(4-chlorophenyl)-2-(4-fluorophenyl)-1,3-dioxo-3a,4,9a,9b-tetrahydropyrrolo[1,2]pyrrolo[3,5-b]pyridazine-4-carboxamide
N-(4-chlorophenethyl)-2-(5-oxo-2,3-dihydrothiazolo[3,2:1,2]pyrimido[5,4-b]indol-6(5H)-yl)acetamide
C22H19ClN4O2S (438.09171840000005)
(4,8-Dihydroxy-17-methoxy-10-oxo-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-14-yl) hydrogen sulate
1-(4-Methoxy-phenyl)-2-[6-methyl-2-(2-oxo-2-p-tolyl-ethylsulfanyl)-pyrimidin-4-ylsulfanyl]-ethanone
C23H22N2O3S2 (438.10717819999996)
riboflavin cyclic 4,5-phosphate
A flavin mononucleotide that is riboflavin (vitamin B2) in which the 4 and 5 hydroxy groups have been converted into a cyclic hydrogen phosphate ester.
VU 6008667
C24H17ClF2N2O2 (438.09465559999995)
VU 6008667 is a selective negative allosteric modulator of M5 NAM with IC50s of 1.2 μM and 1.6 μM for human M5 and rat M5, respectively. High CNS penetration[1].
{4-[(1s,3ar,4s,6ar)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenyl}oxidanesulfonic acid
3,10-dihydroxy-9-{[6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}benzo[c]chromen-6-one
methyl 3-(3,4-dihydroxyphenyl)-2-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoate
2-{2-[2-(2-isopropyl-4-methyl-5h-1,3-thiazol-4-yl)-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl}-4-methyl-1,3-thiazole
methyl 2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carboxylate
(2r,3s)-7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one
methyl 2',6-dihydroxy-5'-[(2s,3s)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylate
7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one
ethyl 7-bromo-4,6-dihydroxy-1-isopropyl-3a,8-dimethyl-5-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-4-carboxylate
C21H27BrO5 (438.10417520000004)
ethyl (1r,3ar,4r,9br)-7-bromo-4,6-dihydroxy-1-isopropyl-3a,8-dimethyl-5-oxo-1h,2h,3h,9bh-cyclopenta[a]naphthalene-4-carboxylate
C21H27BrO5 (438.10417520000004)